CoChat

Inflammation: A Novel Therapeutic Target/Direction in Atherosclerosis

Open access
Li, Bin, Li, Weihong, Li, Xiaoli, Zhou, Hong · 2017 · Current Pharmaceutical Design

The DOI matches its Crossref record; 194 of the 196 references it cites were found in a registry or an index.

Abstract

Over the past two decades, the viewpoint of atherosclerosis has been replaced gradually by a lipiddriven, chronic, low-grade inflammatory disease of the arterial wall. Current treatment of atherosclerosis is focused on limiting its risk factors, such as hyperlipidemia or hypertension. However, treatment targeting the inflammatory nature of atherosclerosis is still very limited and deserves further attention to fight atherosclerosis successfully. Here, we review the current development of inflammation and atherosclerosis to discuss novel insights and potential targets in atherosclerosis, and to address drug discovery based on anti-inflammatory strategy in atherosclerotic disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2174/1381612822666161230142931

Cites

194 of 194 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 194 references

Research works printed but not linked: 1

  1. [171]Bonnefont-Rousselot D. Lp-PLA, a biomarker of vascular inflammation and vulnerability of atherosclerosis plaques. Ann. Pharm. Fr. 2016 74 190 197 26499399

Cited by

See all 137

Metadata

Authors
Li, B., Li, W., Li, X., & Zhou, H.
Affiliations
  • Army Medical University (CN)
  • Chongqing Medical University (CN)
Corresponding author
Zhou, Hong
Venue
Current Pharmaceutical Design
Published
2017-04-12
Volume
23
Issue
8
Pages
1216-1227
ISSN
1381-6128 (ISSN-L)
OpenAlex
W2572385011
Cited by
130
References
196
Citations by year
2026: 4 · 2025: 7 · 2024: 8 · 2023: 15 · 2022: 31 · 2021: 34 · 2020: 18 · 2019: 10 · 2018: 2 · 2017: 1
FWCI
0.87
Type
journal article
Language
en
Open access
Locations
  • Current Pharmaceutical Design (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Keywords
atherosclerosis, inflammation, anti-inflammatory therapy, therapeutic target, drug discovery, low-grade inflammation, arterial wall, hyperlipidemia, hypertension
MeSH terms
Animals, Anti-Inflammatory Agents, Humans, Inflammation, Atherosclerosis, Drug Discovery

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Inflammation: A Novel Therapeutic Target/Direction in Atherosclerosis. https://app.cochat.ai/papers/10.2174/1381612822666161230142931
The paper
Li, B., Li, W., Li, X., & Zhou, H. (2017). Inflammation: A Novel Therapeutic Target/Direction in Atherosclerosis. Current Pharmaceutical Design. https://doi.org/10.2174/1381612822666161230142931

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.